חובות לטווח קצר של החברה: ESSA Pharma Inc. (EPIX)

ESSA Pharma Inc. (EPIX) is developing targeted therapies for female and male oncological diseases, minimizing strategic threats through pipeline diversification. Debt maturing within one year reflects current liabilities, where the indicator stands at 0.00. ESSA Pharma Inc. (EPIX) occupies a unique niche in treating resistant forms of cancer, establishing significant patent barriers to protect its innovative developments within a fierce research race.

This indicator measures the volume of liabilities with a maturity of up to one year, reflecting the business's ability to service current payments without raising emergency capital. By analyzing short-term debt, investors assess the liquidity risk of ESSA Pharma Inc. (EPIX), which is critical given the absence of revenue and the company's total dependence on external financing for costly oncology research.